Table 5 Subgroup analysis of outcomes based on the delivery type
Variable (Score range) | Baseline | Post-intervention | Vaginal compared to cesarean delivery AMD (95% CI)a | Interaction between study groups and delivery types (P-value) | ||
|---|---|---|---|---|---|---|
Vaginal delivery (n= 27) | Cesarean delivery (n= 37) | Vaginal delivery (n= 27) | Cesarean delivery (n= 37) | |||
Total FSFI score (2-36) | Â | Â | Â | Â | 0.507 | |
Oxytocin (n= 34) | 20.8 (4.3) | 18.9 (4.8) | 26.1 (5.9) | 28.1 (4.8) | -3.1 (-6.5 to 0.4) |  |
Placebo (n= 30) | 21.7 (4.1) | 23.0 (4.3) | 26.6 (4.4) | 30.1 (4.7) | -2.9 (-6.2 to 0.3) |  |
Total sexual satisfaction (30-150) | Â | Â | Â | 0.810 | ||
Oxytocin (n= 34) | 93.5 (19.7) | 100.4 (16.7) | 100.7 (23.2) | 108.8 (21.1) | -1.1 (-10.8 to 8.5) |  |
Placebo (n= 30) | 114.0 (13.9) | 103.3 (16.9) | 116.8 (14.0) | 108.6 (18.9) | -2.1 (-7.8 to 3.5) |  |
Depression (0-30) | Â | Â | Â | Â | Â | 0.437 |
Oxytocin (n= 34) | 7.0 (4.2) | 7.3 (3.1) | 4.3 (2.3) | 4.7 (2.0) | -0.2 (-1.1 to 0.6) |  |
Placebo (n= 30) | 6.6 (3.2) | 8.5 (3.0) | 6.0 (2.5) | 7.4 (2.1) | -0.1 (-1.3 to 1.0) |  |